| Model Number |
04T7520 |
| Medical Device Problem Code |
High Test Results (2457)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
10/29/2021
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
The customer observed (b)(6) alinity i insulin results on a newborn baby.The initial result on (b)(6) 2021 for sid (b)(4) was (b)(6) uu/ml normal ((b)(6) to (b)(6) uu/ml), the second sample sid (b)(4) had an initial result of (b)(6) uu/ml, repeated (b)(6) / (b)(6) / (b)(6) / (b)(6) / (b)(6) / (b)(6) / (b)(6) / (b)(6) uu/ml.No impact to patient management was reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Patient identifier: sid sid (b)(4).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
| |
|
Additional Manufacturer Narrative
|
|
The ticket search by lot indicates that the reagent lot perform as expected for this product.Return testing was not completed as returns were not available.Trending review did not identify any trends for the complaint issue.Device history record review did not identify any issues associated with lot 97511lp66 and the complaint issue.Accuracy testing was performed to evaluate the performance of reagent lot 97511lp66.An internal alinity i insulin panel was tested with retained kits of the likely cause reagent lot.Acceptance criteria was met, which indicates acceptable product performance.Labeling was reviewed and found to adequately address the issue of falsely elevated results.Based on the investigation, no systemic issue or deficiency of the alinity i insulin reagent lot 97511lp66 was identified.
|
| |
|
Search Alerts/Recalls
|